Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atezolizumab and Bevacizumab With Stereotactic Body Radiotherapy for Advanced Hepatocellular Carcinoma

NCT06595108 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT06595108
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06595108 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atezolizumab and Bevacizumab With Stereotactic Body Radiotherapy for Advanced Hepatocellular Carcinoma
Lead sponsor
Yonsei University
Phase
Not applicable
Overall status
Recruiting
Start date
May 28, 2024
Completion date
March 27, 2028
Enrollment
33 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced hepatocellular carcinoma, chemotherapy, stereotactic body radiotherapy